Bcg Vaccine Ajv

BCG Vaccine AJV is a live attenuated vaccine used to prevent tuberculosis. It contains Mycobacterium bovis, Danish Strain 1331, and is administered intradermally. This vaccine is suitable for specific age groups and populations as recommended by healthcare providers.

BCG Vaccine AJV is primarily used for the prevention of tuberculosis, a bacterial infection that mainly affects the lungs. It is often administered to infants and children in regions where tuberculosis is prevalent. The vaccine works by stimulating the immune system to recognize and fight off the bacteria that cause tuberculosis. Healthcare providers may also recommend this vaccine for individuals at high risk of exposure to tuberculosis.

Common effects of BCG Vaccine AJV may include redness, swelling, or a small bump at the injection site. These reactions are usually mild and temporary. Some individuals may experience a low-grade fever or mild flu-like symptoms. Severe reactions are rare but should be reported to a healthcare provider immediately.

BCG Vaccine AJV should be handled with care and stored as recommended to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems or certain chronic illnesses may not be suitable candidates for this vaccine. Always follow the advice of a healthcare professional regarding vaccination.

BCG Vaccine AJV may interact with certain medications that affect the immune system. It is important to discuss all current medications with a healthcare provider before receiving the vaccine. Additionally, individuals who have recently received other live vaccines should consult their healthcare provider to determine the appropriate timing for BCG vaccination.